Medycyna Paliatywna

Abstract

4/2018 vol. 10
Original paper

Quality of life assessment in multiple myeloma patients – preliminary report

Medycyna paliatywna 2018; 10(4): 208–215
Online publish date: 2019/03/04
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

Multiple myeloma (MM) is a result of abnormal proliferation of plasma cells, and it represents approximately 10% of all new haematological neoplasms. MM is connected with overproduction of abnormal antibodies, which can lead to hyperviscosity syndrome and impaired microvascular circulation.

Material and methods

We report a study of 95 patients (61 women and 34 men) with multiple myeloma. The mean age was 62.34 ±8.52 years. In the research we used the following questionnaire: a questionnaire of the patient’s physical state (the Karnofsky scale), the Hospital Anxiety and Depression Scale (HADS), the Zung Self-Rating Depression Scale, and the QLQ-MY20 scale to assess patients’ quality of life.

Results

Analysis of results and collected data showed that nearly 50% patients had noticeable anxiety disorders, while almost 30% presented symptoms of depression in the HADS scale. Additionally, analysis of data obtained using the Zung scale revealed that more than 50% of the examined patients had depression symptoms of varying degrees of severity. We indicated significant correlation between patients’ age and depression symptoms in the Zung scale (p < 0.001). Patients with more severe pain, depression symptoms, and lower physical state complained of significantly lower quality of life (p < 0.05).

Conclusions

Intensity of pain and number of painful areas significantly reduce the quality of life. Reduction of physical state and severity of depression symptoms have a significant negative influence on quality of life. Older patients complain about more severe depression symptoms.

Share
without publication fees
without publication fees